Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty
Could Halozyme Therapeutics be the next big opportunity in biotech? Join our experts as they dissect the company's strengths and weaknesses, revealing what...
Can Apple Stock Reach $350 in 2026?
Apple bulls hope that the consumer tech giant's shares can rise 35% before this year is over.Since it first purchased Apple (AAPL 0.93%)...
Construction firm Italian-Thai Development is under fire after consecutive crane collapses
Italian-Thai Development, one of Thailand’s largest construction conglomerates, is in the spotlight after successive fatal incidents on its building sites.
On Jan. 14, a...
Can Nike Stock Reach $100 in 2026?
Nike bulls are hoping the business can get back to its winning ways soon.Nike (NKE 0.33%) is one of the leading consumer-facing brands...
Moscow cheers NATO crisis as Ukraine war stifles Russian economy and forces companies to 4-day weeks
President Donald Trump’s feud with NATO over his plans to take over Greenland has precipitated an existential crisis for the alliance that Russia...
The Crypto ETF Showdown: BITQ’s Diversification vs. IBIT’s Bitcoin Bet
Explore how these two crypto ETFs differ in cost, risk, and portfolio approach -- key factors for aligning with your investment strategy.The iShares...